Toggle navigation
Home
Search
Services
Blog
Contact
About
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul
Yale University, New Haven, CT, United States
Search 3 grants from Paul Lebowitz
Search grants from Yale University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Biophysics of Protein Disorder and Complexity, Single Molecules to Mesoscales
Robot-Assisted Mobility for Infants with Severe Spina Spina
Adriamycin-Induced Mitochondrial Cardiomyopathy
The Biochemical Basis of Behavioral Plasticity
Src Proteins and Cellular Transformed Phenotypes
Recently added grants:
Mechanisms of enhancer regulation in leukemia
Direct Small Molecule Activation of Pro-apoptotic BAK
Molecular mechanisms of estrogen receptor-dependent transcription regulation
Regulation by mTORC1 of the lysosomal efflux of essential amino acids
Couple Communication Skills Training for Advanced Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA049238-02
Application #
3193270
Study Section
Pathology B Study Section (PTHB)
Project Start
1989-01-09
Project End
1991-12-31
Budget Start
1990-01-01
Budget End
1990-12-31
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Institution
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Related projects
NIH 1991
R01 CA
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul / Yale University
NIH 1990
R01 CA
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul / Yale University
NIH 1989
R01 CA
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul / Yale University
Publications
Morris, S W; Daniel, L; Ahmed, C M et al.
(1990)
Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase.
Blood 75:2035-41
Comments
Be the first to comment on Paul Lebowitz's grant